Latest News about NVS
Recent news which mentions NVS
   Novartis Injects $300M In Early-Stage Biologics Research Tech
   
  September 12, 2022
  Tickers 
   NVS
  
  
  From Benzinga
 
   Novartis' Kisqali Adds One More Year Of Survival Benefit In Breast Cancer Setting
   
  September 09, 2022
  Tickers 
   NVS
  
  
  From Benzinga
 
   No Early Relief for JW Therapeutics from Cancer Wonder Drug
   
  
  
  September 07, 2022
  From Benzinga
 From Benzinga
 
   Novartis Appoints Merck Executive As Research Head
   
  
  
  September 01, 2022
  From Benzinga
 From Benzinga
 
   U.S.-China relations just got a whole lot better, boosting the prospects of these three stocks
   
  
  
  August 28, 2022
  From MarketWatch
 
   With Sandoz Spinoff, Novartis Slams Brakes On Huntington's Trial
   
  August 25, 2022
  Tickers 
   NVS
  
  
  From Benzinga
 From Benzinga
 
   Fed heroics or no, the S&P 500 level is destined for a retest of lows. These are the levels to watch, says this strategist
   
  
  
  August 25, 2022
  From MarketWatch
 
   Caribou's Blood Cancer Candidate Shows Response Rates Better Than Novartis,' This Analyst Writes
   
  
  
  August 18, 2022
  From Benzinga
 
   A Look Into Healthcare Sector Value Stocks
   
  
  
  August 15, 2022
  From Benzinga
 From Benzinga
 From Benzinga
 
   Deciphera's Cancer Drug Tops Pfizer's Sutent On Safety Front In Gastrointestinal Cancer
   
  
  
  August 11, 2022
  From Benzinga
 
   Smaller Biotechs May Pave Way For New Generation Of Therapeutics For Hard-to-Treat Neurological Disorders
   
  
  
  August 08, 2022
  From Benzinga
 From Benzinga
 Tickers 
   NVS
  
  
  From Motley Fool
 
   Alnylam's Strategy Is Getting Bigger. Time to Buy?
   
  
  
  July 30, 2022
  From Motley Fool
 From Benzinga
 
   This Biotech Says Stem Cells May Be Key To Freeing 65 Million Americans From Chronic Back Pain, Painkiller Dependence
   
  
  
  July 27, 2022
  From Benzinga
 
   7 Cathie Wood Stocks Trading at a Discount Right Now
   
  
  
  July 26, 2022
  From InvestorPlace
 From Benzinga
 From Benzinga
 From Benzinga
 
   What This FDA Delay Means for Novartis
   
  
  
  July 21, 2022
  From Motley Fool
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.
 

